The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison.

The Ministry of Health in the Netherlands has made illicit drug testing for drug users possible since the 1990s, in order to prevent serious health hazards associated with unexpected dangerous substances. This system of illicit drug testing is called the Drug Information and Monitoring System (DIMS). In nearly two decades, more than 100 000 drug samples have been handed in at DIMS testing facilities. This review describes the DIMS methodology and overviews results of the three main psychostimulant drug markets that have been monitored, i.e. ecstasy, amphetamine (speed), and cocaine. Additionally, monitoring results of hallucinogens are also described for the first time. For comparison, alternative international monitoring systems are described briefly alongside some of their results. Finally, drug monitoring is discussed from the perspectives of policy, prevention, and the drug users themselves.

[1]  D. Legatt,et al.  Agranulocytosis after consumption of cocaine adulterated with levamisole. , 2009, Annals of internal medicine.

[2]  R. Niesink,et al.  Strong increase in total delta‐THC in cannabis preparations sold in Dutch coffee shops , 2005, Addiction biology.

[3]  P. V. van Dijk,et al.  An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. , 2009, Addiction.

[4]  S. van Calenbergh,et al.  Fatality due to combined use of the designer drugs MDMA and PMA: a distribution study. , 2003, Journal of analytical toxicology.

[5]  I. Spruit Ecstasy Use and Policy Responses in the Netherlands , 1999 .

[6]  G. Rossoni,et al.  Diazepam protects against the enhanced toxicity of cocaine adulterated with atropine. , 2008, Journal of pharmacological sciences.

[7]  D. Caldicott,et al.  Underground pill testing, down under. , 2005, Forensic science international.

[8]  E. Tanner‐Smith,et al.  Pharmacological content of tablets sold as "ecstasy": results from an online testing service. , 2006, Drug and alcohol dependence.

[9]  Robert G Carlson,et al.  Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users. , 2004, Drug and alcohol dependence.

[10]  H. Neels,et al.  Analysis of drugs of abuse in wastewater by hydrophilic interaction liquid chromatography–tandem mass spectrometry , 2009, Analytical and bioanalytical chemistry.

[11]  Alex Gamma,et al.  Is ecstasy perceived to be safe? A critical survey. , 2005, Drug and alcohol dependence.

[12]  D. Korf,et al.  Pill testing, ecstasy and prevention: a scientific evaluation in three European cities. , 2002 .

[13]  Dong Chen,et al.  Determination of 76 pharmaceutical drugs by liquid chromatography-tandem mass spectrometry in slaughterhouse wastewater. , 2009, Journal of chromatography. A.

[14]  D. N. Sims,et al.  Recent paramethoxyamphetamine deaths , 1998 .

[15]  A. Winstock,et al.  Mephedrone, new kid for the chop? , 2011, Addiction.

[16]  A. Ritter Illicit drugs policy through the lens of regulation. , 2010, The International journal on drug policy.

[17]  E. Gouzoulis-Mayfrank,et al.  Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) , 2000, Journal of neurology, neurosurgery, and psychiatry.

[18]  J. Fisk,et al.  Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study , 2006, Journal of psychopharmacology.

[19]  Kelly Morris,et al.  UK places generic ban on mephedrone drug family , 2010, The Lancet.

[20]  E. Jaehne,et al.  Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia , 2007, Psychopharmacology.

[21]  Jih-Heng Li,et al.  Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005. , 2006, Forensic science international.

[22]  S. Refstad Paramethoxyamphetamine (PMA) poisoning; a ‘party drug’ with lethal effects , 2003, Acta anaesthesiologica Scandinavica.

[23]  E. Kaa,et al.  Narcotics at street level in Denmark. A prospective investigation from 1995 to 2000. , 2003, Forensic science international.

[24]  J. Ramsey,et al.  Analysis for Identification in Amnesty Bin Samples from Dance Venues , 2005, Therapeutic drug monitoring.

[25]  D. Nutt,et al.  Harms associated with psychoactive substances: findings of the UK National Drug Survey , 2010, Journal of psychopharmacology.

[26]  G. Martinotti,et al.  Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002 , 2003, Human psychopharmacology.

[27]  I. Spruit,et al.  MONITORING SYNTHETIC DRUG MARKETS, TRENDS, AND PUBLIC HEALTH , 2001, Substance use & misuse.

[28]  R. Paxton,et al.  Drug education: a review of British Government policy and evidence on effectiveness. , 1999, Health education research.

[29]  S. Legleye,et al.  Two ways of estimating the euro value of the illicit market for cannabis in France. , 2008, Drug and alcohol review.

[30]  Meelee Kim,et al.  Usefulness of prescription monitoring programs for surveillance—analysis of Schedule II opioid prescription data in Massachusetts, 1996–2006 , 2010, Pharmacoepidemiology and drug safety.

[31]  Fiona Measham,et al.  Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition , 2010 .

[32]  Matthew Dunn,et al.  Factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users. , 2009, Drug and alcohol dependence.

[33]  Fabrizio Schifano,et al.  Drugs on the web; the Psychonaut 2002 EU project , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  Isabelle Giraudon,et al.  Monitoring Ecstasy Content in France: Results From the National Surveillance System 1999–2004 , 2007, Substance use & misuse.

[35]  A. Parrott Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity , 2004, Psychopharmacology.

[36]  Marcel de Kort,et al.  Pragmatism versus Ideology: Dutch Drug Policy Continued , 1999 .

[37]  F. Ventura,et al.  Ultraperformance liquid chromatography-tandem mass spectrometry analysis of stimulatory drugs of abuse in wastewater and surface waters. , 2007, Analytical chemistry.

[38]  Shane Darke,et al.  Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for 'party drugs'. , 2004, Drug and alcohol dependence.

[39]  D. Nichols,et al.  Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. , 1986, Journal of psychoactive drugs.

[40]  R. Dinsdale,et al.  Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data. Part 1: Estimation of the usage of drugs in local communities. , 2009, Environmental pollution.

[41]  J. Osterloh,et al.  Levamisole: A Dangerous New Cocaine Adulterant , 2010, Clinical pharmacology and therapeutics.

[42]  H. Goldschmidt The NEXUS vision: an alternative to the reference value concept , 2004, Clinical chemistry and laboratory medicine.

[43]  H. Sumnall,et al.  The confusing case of NRG-1 , 2010, BMJ : British Medical Journal.

[44]  H. Sumnall,et al.  The content of ecstasy tablets: implications for the study of their long-term effects. , 2002, Addiction.

[45]  J. Rehm,et al.  Interventions to reduce harm associated with adolescent substance use , 2007, The Lancet.

[46]  J. Ramsey,et al.  A new method to monitor drugs at dance venues , 2001, BMJ : British Medical Journal.

[47]  P. V. van Dijk,et al.  Content of ecstasy in the Netherlands: 1993-2008. , 2009, Addiction.

[48]  J. Vogel,et al.  Levamisole-Induced Occlusive Necrotizing Vasculitis of the Ears After Use of Cocaine Contaminated with Levamisole , 2011, Journal of Medical Toxicology.

[49]  Ettore Zuccato,et al.  Estimating Community Drug Abuse by Wastewater Analysis , 2008, Environmental health perspectives.

[50]  C. Banta-Green,et al.  Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in U.S. wastewaters. , 2008, Environmental science & technology.

[51]  J. Mounteney,et al.  Earlier warning: a multi-indicator approach to monitoring trends in the illicit use of medicines. , 2009, The International journal on drug policy.

[52]  G. Dumyati,et al.  Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. , 2010, Annals of internal medicine.

[53]  S. C. Lahiri,et al.  Qualitative and quantitative analysis of seized street drug samples and identification of source. , 2005, Forensic science international.

[54]  J. Kraner,et al.  Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA). , 2001, Journal of analytical toxicology.